Literature DB >> 8389776

24th Bethesda conference: Cardiac transplantation. Task Force 5: Complications.

L W Miller, R C Schlant, J Kobashigawa, S Kubo, D G Renlund.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 8389776     DOI： 10.1016/0735-1097(93)90814-h

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  12 in total

1.  Permanent pacing for asystole of the donor heart after heterotopic heart transplantation.

Authors:  G Kalife; B Radovancević; S Fighali
Journal:  Tex Heart Inst J       Date:  1997

Review 2.  Low-density lipoprotein apheresis in the treatment of atherosclerosis and other potential uses.

Authors:  P M Moriarty; C A Gibson
Journal:  Curr Atheroscler Rep       Date:  2001-03       Impact factor: 5.113

Review 3.  Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Use for Atherogenic Dyslipidemia in Solid Organ Transplant Patients.

Authors:  Gianluigi Cuomo; Giuseppe Cioffi; Anna Di Lorenzo; Francesca Paola Iannone; Giuseppe Cudemo; Anna Maria Iannicelli; Mario Pacileo; Antonello D'Andrea; Carlo Vigorito; Gabriella Iannuzzo; Francesco Giallauria
Journal:  J Clin Med       Date:  2022-06-06       Impact factor: 4.964

4.  Donor-specific antibodies to class II antigens are associated with accelerated cardiac allograft vasculopathy: a three-dimensional volumetric intravascular ultrasound study.

Authors:  Yan Topilsky; Manish J Gandhi; Tal Hasin; Laurie L Voit; Eugenia Raichlin; Barry A Boilson; John A Schirger; Brooks S Edwards; Alfredo L Clavell; Richard J Rodeheffer; Robert P Frantz; Sudhir S Kushwaha; Amir Lerman; Naveen L Pereira
Journal:  Transplantation       Date:  2013-01-27       Impact factor: 4.939

Review 5.  Management of hyperlipidaemia associated with heart transplantation.

Authors:  Klaus Wenke
Journal:  Drugs       Date:  2004       Impact factor: 9.546

6.  Combined heart and liver transplant attenuates cardiac allograft vasculopathy compared with isolated heart transplantation.

Authors:  Yan Topilsky; Eugenia Raichlin; Tal Hasin; Barry A Boilson; John A Schirger; Naveen L Pereira; Brooks S Edwards; Alfredo L Clavell; Richard J Rodeheffer; Robert P Frantz; Manish J Gandhi; Simon Maltais; Soon J Park; Richard C Daly; Amir Lerman; Sudhir S Kushwaha
Journal:  Transplantation       Date:  2013-03-27       Impact factor: 4.939

Review 7.  Graft vessel disease following heart transplantation: a systematic review of the role of statin therapy.

Authors:  Robin Som; Peter J Morris; Simon R Knight
Journal:  World J Surg       Date:  2014-09       Impact factor: 3.352

Review 8.  Clinical recommendations for postoperative care after heart transplantation in children: 21 years of a single-center experience.

Authors:  Estela Azeka; Marcelo Biscegli Jatene; Ana Cristina Tanaka; Filomena Regina Galas; Ludhmilla Abrahao Hajjar; Nana Miura; Jose Otavio Costa Auler Junior
Journal:  Clinics (Sao Paulo)       Date:  2014       Impact factor: 2.365

Review 9.  An Update on Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Health.

Authors:  Andrew Elagizi; Carl J Lavie; Evan O'Keefe; Keri Marshall; James H O'Keefe; Richard V Milani
Journal:  Nutrients       Date:  2021-01-12       Impact factor: 5.717

10.  Impact of animal strain on gene expression in a rat model of acute cardiac rejection.

Authors:  Katherine J Deans; Peter C Minneci; Hao Chen; Steven J Kern; Carolea Logun; Sara Alsaaty; Kelly J Norsworthy; Stephanie M Theel; Joel D Sennesh; Jennifer J Barb; Peter J Munson; Robert L Danner; Michael A Solomon
Journal:  BMC Genomics       Date:  2009-06-24       Impact factor: 3.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.